In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Clorox Co (NYSE: CLX) closed at $145.16 up 0.19% from its previous closing price of $144.88. In other words, the price has increased by $0.19 from its previous closing price. On the day, 1.11 million shares were traded. CLX stock price reached its highest trading level at $145.36 during the session, while it also had its lowest trading level at $144.0.
Ratios:
For a deeper understanding of Clorox Co’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 61.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.73. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 0.94.
On November 06, 2024, TD Cowen Upgraded its rating to Hold which previously was Sell and also upped its target price recommendation from $155 to $170.
Jefferies Upgraded its Hold to Buy on October 01, 2024, whereas the target price for the stock was revised from $174 to $187.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 10 ’25 when Marriner Kirsten sold 7,494 shares for $151.62 per share. The transaction valued at 1,136,251 led to the insider holds 27,038 shares of the business.
Marriner Kirsten sold 733 shares of CLX for $109,950 on Mar 11 ’25. The EVP – Chief People Officer now owns 26,305 shares after completing the transaction at $150.00 per share. On Mar 10 ’25, another insider, Marriner Kirsten, who serves as the Officer of the company, bought 8,227 shares for $152.35 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 17882261504 and an Enterprise Value of 20830842880. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.67, and their Forward P/E ratio for the next fiscal year is 19.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50. Its current Enterprise Value per Revenue stands at 2.907 whereas that against EBITDA is 16.678.
Stock Price History:
The Beta on a monthly basis for CLX is 0.61, which has changed by -0.016930759 over the last 52 weeks, in comparison to a change of 0.08275449 over the same period for the S&P500. Over the past 52 weeks, CLX has reached a high of $171.37, while it has fallen to a 52-week low of $127.60. The 50-Day Moving Average of the stock is -5.49%, while the 200-Day Moving Average is calculated to be -5.24%.
Shares Statistics:
For the past three months, CLX has traded an average of 1.44M shares per day and 1701130 over the past ten days. A total of 123.15M shares are outstanding, with a floating share count of 122.82M. Insiders hold about 0.30% of the company’s shares, while institutions hold 82.44% stake in the company. Shares short for CLX as of 1740700800 were 4324672 with a Short Ratio of 3.01, compared to 1738281600 on 3854656. Therefore, it implies a Short% of Shares Outstanding of 4324672 and a Short% of Float of 4.01.
Dividends & Splits
According to the company, the forward annual dividend rate for CLX is 4.86, from 4.86 in the trailing year. Against a Trailing Annual Dividend Yield of 0.033545002The stock’s 5-year Average Dividend Yield is 2.88. The current Payout Ratio is 214.84% for CLX, which recently paid a dividend on 2025-01-29 with an ex-dividend date of 1745366400. Stock splits for the company last occurred on 1999-08-24 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 15.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $2.2, with high estimates of $2.48 and low estimates of $1.96.
Analysts are recommending an EPS of between $7.41 and $7.03 for the fiscal current year, implying an average EPS of $7.22. EPS for the following year is $7.35, with 19.0 analysts recommending between $7.89 and $6.83.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $1.74B this quarter.It ranges from a high estimate of $1.77B to a low estimate of $1.72B. As of the current estimate, Clorox Co’s year-ago sales were $1.81BFor the next quarter, 12 analysts are estimating revenue of $1.95B. There is a high estimate of $2.02B for the next quarter, whereas the lowest estimate is $1.87B.
A total of 18 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.24B, while the lowest revenue estimate was $7.06B, resulting in an average revenue estimate of $7.14B. In the same quarter a year ago, actual revenue was $7.09BBased on 18 analysts’ estimates, the company’s revenue will be $7.25B in the next fiscal year. The high estimate is $7.42B and the low estimate is $7.06B.
